The stock gained more than 1% in pre-market on Aug. 19, 2025. FDA Gives Green Signal to Wegovy for MASH On Friday, the company announced that Wegovy had been approved for the treatment of metabolic ...

This episode of Pharma Pulse covers Novo Nordisk’s FDA win for Wegovy in MASH-related liver fibrosis, new research on a ...

Trump’s possible next move, Winklevoss twins jump into hot IPO market, Palo Alto Networks issues rosy guidance, and more news to start your day.

An outbreak of Legionnaires’ disease in City’s Harlem neighborhood thought to have originated in contaminated cooling towers ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...